Crucially, we could not adequately account for critical variables such as MG autoantibody subtype (AChR, MuSK, LRP4), patient age, and specific immunosuppressive regimens-all of which are known to influence infection risks and therapeutic responses (Gilhus et al., 2018; Nelke et al., 2022). The gene discussed is MUSK; the disease is myasthenia gravis.